BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7545481)

  • 1. Controlled release of poly-D,L-lactic acid containing bleomycin.
    Nakamura K; Natsugoe S; Kumanohoso T; Aikou T; Shinkawa T; Yamada K; Fukuzaki H
    Anticancer Drugs; 1995 Jun; 6(3):483-7. PubMed ID: 7545481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A basic study on usefulness of bleomycin incorporated in poly DL-lactic acid].
    Kumanohoso T; Natsugoe S; Shimada M; Sagara M; Aikou T; Shimazu H; Shinkawa T; Nakamura K; Fukuzaki H
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1572-4. PubMed ID: 7690536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug distribution and antitumor effect of bleomycin incorporated in poly DL-lactic acid in rats].
    Kumanohoso T; Natsugoe S; Tokuda K; Shimada M; Sagara M; Shinkawa T; Nakamura K; Yamada K; Fukuzaki H; Aikou T
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2248-50. PubMed ID: 7524449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo activity of bleomycin incorporated with biodegradable poly-d,l-lactic acid and implanted in the mediastinum of dogs.
    Kumanohoso T; Natsugoe S; Shimada M; Aikou T; Nakamura K; Yamada K; Fukuzaki H
    J Surg Oncol; 1994 Nov; 57(3):178-82. PubMed ID: 7526072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of therapeutic efficacy of bleomycin by incorporation into biodegradable poly-d,l-lactic acid.
    Kumanohoso T; Natsugoe S; Shimada M; Aikou T
    Cancer Chemother Pharmacol; 1997; 40(2):112-6. PubMed ID: 9182831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
    Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
    Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight PLA: a suitable polymer for pulmonary administered microparticles?
    Wichert B; Rohdewald P
    J Microencapsul; 1993; 10(2):195-207. PubMed ID: 8392542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of release rate of tetanus vaccine from polyester microspheres.
    Alonso MJ; Cohen S; Park TG; Gupta RK; Siber GR; Langer R
    Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled protein release from polyethyleneimine-coated poly(L-lactic acid)/pluronic blend matrices.
    Park TG; Cohen S; Langer R
    Pharm Res; 1992 Jan; 9(1):37-9. PubMed ID: 1589407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microencapsulation using poly(DL-lactic acid). III: Effect of polymer molecular weight on the release kinetics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):357-74. PubMed ID: 2384838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable poly(DL-lactic acid) formulations in a calcitonin delivery system.
    Asano M; Yoshida M; Omichi H; Mashimo T; Okabe K; Yuasa H; Yamanaka H; Morimoto S; Sakakibara H
    Biomaterials; 1993 Aug; 14(10):797-9. PubMed ID: 8218732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(1):53-66. PubMed ID: 2308054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrone loaded poly(l-lactic acid) microspheres: preparation, evaluation and in vitro release kinetics.
    Parikh BV; Upadrashta SM; Neau SH; Nuessle NO
    J Microencapsul; 1993; 10(2):141-53. PubMed ID: 8331489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight poly(lactic acid) microparticles for controlled release of the herbicide metazachlor: preparation, morphology, and release kinetics.
    Stloukal P; Kucharczyk P; Sedlarik V; Bazant P; Koutny M
    J Agric Food Chem; 2012 Apr; 60(16):4111-9. PubMed ID: 22480233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of cisplatin incorporated into biodegradable poly-d, l-lactic acid.
    Natsugoe S; Kumanohoso T; Tokuda K; Shimada M; Mueller J; Nakamura K; Yamada K; Fukuzaki H; Aikou T
    Anticancer Res; 1997; 17(3C):1957-60. PubMed ID: 9216651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled cisplatin delivery system using poly(D,L-lactic acid).
    Ike O; Shimizu Y; Wada R; Hyon SH; Ikada Y
    Biomaterials; 1992; 13(4):230-4. PubMed ID: 1520828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microencapsulation using poly(DL-lactic acid). I: Effect of preparative variables on the microcapsule characteristics and release kinetics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(2):229-44. PubMed ID: 2329448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.